CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 51472-51665 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T296","span":{"begin":0,"end":193},"obj":"Sentence"},{"id":"T70614","span":{"begin":0,"end":193},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In the follow up research [115] , the potent compound 160 (Fig. 15 ) was selected from the novel synthesized analogues with excellent activity and free from cytotoxicity (\u003e62.5 mg/mL) appeared."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T10","span":{"begin":0,"end":193},"obj":"Sentence"}],"text":"In the follow up research [115] , the potent compound 160 (Fig. 15 ) was selected from the novel synthesized analogues with excellent activity and free from cytotoxicity (\u003e62.5 mg/mL) appeared."}